All Stories

  1. Incidence of chronic intestinal failure due short bowel syndrome in adults: A feasibility study
  2. Very long-term central venous access device for home parenteral nutrition in adults: A center-based cross-sectional survey
  3. Prediction of chronic severe intestinal failure–associated liver disease by current criteria in adults: A descriptive cohort study
  4. Operational recommendations for the implementation of home parenteral nutrition program of care according to the guidelines of the European society for clinical nutrition and metabolism
  5. Baseline Characteristics of Adult Patients Treated and Never Treated with Teduglutide in a Multinational Short Bowel Syndrome and Intestinal Failure Registry
  6. The gut microbiota in adults with chronic intestinal failure
  7. Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease
  8. ESPEN guideline on chronic intestinal failure in adults – Update 2023
  9. Value of immunonutrition in patients undergoing pancreatic resection: a trial sequential meta-analysis
  10. Attitudes towards Vaccinations in a National Italian Cohort of Patients with Inflammatory Bowel Disease
  11. Use of teduglutide in adults with short bowel syndrome–associated intestinal failure
  12. COVID-19 infection in patients on long-term home parenteral nutrition for chronic intestinal failure
  13. Definition, classification, and causes of short bowel syndrome
  14. Management of acute mesenteric ischaemia: Results of a worldwide survey
  15. Survey of healthcare professionals' experiences of care delivery in patients with chronic intestinal failure: ATLAS of Variance
  16. ESPEN practical guideline: Home parenteral nutrition
  17. Patients, family members and healthcare professionals’ top ten research priorities for adults receiving home parenteral nutrition for malignant or benign disease
  18. Long‐term survival following fungal catheter‐related bloodstream infection for patients with intestinal failure receiving home parenteral support
  19. Anatomical Laser Microdissection of the Ileum Reveals mtDNA Depletion Recovery in A Mitochondrial Neuro-Gastrointestinal Encephalomyopathy (MNGIE) Patient Receiving Liver Transplant
  20. Effect of malnutrition on postoperative results after pancreatic resection: An entropy balancing analysis
  21. Chronic Intestinal Failure in Children: An International Multicenter Cross-Sectional Survey
  22. Preoperative carbohydrate loading before elective abdominal surgery: A systematic review and network meta-analysis of phase II/III randomized controlled trials
  23. Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: An international multicenter survey
  24. ESPEN practical guideline: Clinical nutrition in chronic intestinal failure
  25. The safety of available treatment options for short bowel syndrome and unmet needs
  26. Candidacy of adult patients with short bowel syndrome for treatment with glucagon-like peptide-2 analogues: A systematic analysis of a single centre cohort
  27. Malnutrition and nutritional therapy in patients with SARS-CoV-2 disease
  28. Effects of antidiabetic agents on steatosis and fibrosis biomarkers in type 2 diabetes: A real‐world data analysis
  29. Reply to the comment by CHEN W et al. on the ESPEN HPN guidelines
  30. An International Survey of Clinicians’ Experience Caring for Patients Receiving Home Parenteral Nutrition for Chronic Intestinal Failure During the COVID‐19 Pandemic
  31. A Call to Action: Now Is the Time to Screen Elderly and Treat Osteosarcopenia, a Position Paper of the Italian College of Academic Nutritionists MED/49 (ICAN-49)
  32. ESPEN guideline on home parenteral nutrition
  33. Intravenous supplementation type and volume are associated with 1-year outcome and major complications in patients with chronic intestinal failure
  34. Translation of Evidence Into Practice With Teduglutide in the Management of Adults With Intestinal Failure due to Short‐Bowel Syndrome: A Review of Recent Literature
  35. Assessment of Intestinal Failure Associated Liver Disease according to different diagnostic criteria
  36. Outcome of kidney function in adults on long-term home parenteral nutrition for chronic intestinal failure
  37. Home parenteral nutrition provision modalities for chronic intestinal failure in adult patients: An international survey
  38. Intestinal failure in adults: Recommendations from the ESPEN expert groups
  39. Clinical approach to the management of Intestinal Failure Associated Liver Disease (IFALD) in adults: A position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN
  40. Reversal of intestinal failure associated liver disease fibrosis in a patient receiving long term home parenteral nutrition
  41. Five-year survival and causes of death in patients on home parenteral nutrition for severe chronic and benign intestinal failure
  42. Clinical classification of adult patients with chronic intestinal failure due to benign disease: An international multicenter cross-sectional survey
  43. Cerebral Mitochondrial Microangiopathy Leads to Leukoencephalopathy in Mitochondrial Neurogastrointestinal Encephalopathy
  44. Home parenteral nutrition (HPN) in patients with post-bariatric surgery complications
  45. Revised ESPEN Clinical Classification of Chronic Intestinal Failure: From 16 to 8 Categories
  46. Liver transplant reverses biochemical imbalance in mitochondrial neurogastrointestinal encephalomyopathy
  47. Corrigendum to “ESPEN guidelines on chronic intestinal failure in adults” [Clin Nutr 35 (2) (2016) 247–307]
  48. Development of home artificial nutrition in Italy over a seven year period: 2005–2012
  49. Functional lipidomics in patients on home parenteral nutrition: Effect of lipid emulsions
  50. Management of acute intestinal failure: A position paper from the European Society for Clinical Nutrition and Metabolism (ESPEN) Special Interest Group
  51. Reply, Letter to the Editor – Primary thromboprophylaxis for adult patients on home parenteral nutrition: A comment on the 2016 ESPEN guideline
  52. Liver transplantation for mitochondrial neurogastrointestinal encephalomyopathy
  53. Reply to Letter to the Editor – Intestinal failure definition and classification comments
  54. Definitions of intestinal failure and the short bowel syndrome
  55. ESPEN guidelines on chronic intestinal failure in adults
  56. ITA-MNGIE: an Italian regional and national survey for mitochondrial neuro-gastro-intestinal encephalomyopathy
  57. Prospective study of catheter-related central vein thrombosis in home parenteral nutrition patients with benign disease using serial venous Doppler ultrasound
  58. Development and validation of a nomogram to predict survival in incurable cachectic cancer patients on home parenteral nutrition
  59. Iodine status in intestinal failure in adults
  60. Plasma citrulline after small bowel transplantation: effect of time from transplantation, acute cellular rejection, and renal failure
  61. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults
  62. Indications and Timing for Intestinal/Multivisceral Transplantation
  63. Correction: Liver as a Source for Thymidine Phosphorylase Replacement in Mitochondrial Neurogastrointestinal Encephalomyopathy
  64. Effect of Age on Native Kidney Function after Adult Intestinal Transplants on Long-Term Follow-up
  65. Iodine nutrition in adults on long-term home parenteral nutrition
  66. Long-Term Endoscopic Follow-up in Small Bowel Transplant Recipients: Single-Center Series
  67. Renal function in patients on long-term home parenteral nutrition and in intestinal transplant recipients
  68. Outcome Indicators for Home Parenteral Nutrition Care
  69. Transient Elastography (FibroScan) Is Not Correlated With Liver Fibrosis but With Cholestasis in Patients With Long-Term Home Parenteral Nutrition
  70. Liver as a Source for Thymidine Phosphorylase Replacement in Mitochondrial Neurogastrointestinal Encephalomyopathy
  71. The prognosis of incurable cachectic cancer patients on home parenteral nutrition: a multi-centre observational study with prospective follow-up of 414 patients
  72. Intravenous Lipids in Home Parenteral Nutrition
  73. Disease-Related Intestinal Transplant in Adults: Results From a Single Center
  74. Isolated Intestinal Transplant for Chronic Intestinal Pseudo-Obstruction in Adults: Long-Term Outcome
  75. Operative Endoscopy for Treatment of Native Rectal Post-Transplantation Lymphoproliferative Disease After Adult Small Bowel Transplantation: A Case Report
  76. Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide – Analyses from a randomised, placebo-controlled study
  77. Extracorporeal Photopheresis for Chronic GVHD
  78. Induction therapy in adult intestinal transplantation: reduced incidence of rejection with “2-dose” alemtuzumab protocol
  79. Mortality After Steroid-Resistant Acute Cellular Rejection and Chronic Rejection Episodes in Adult Intestinal Transplants: Report From a Single Center in Induction/Preconditioning Era
  80. Development of quality of care interventions for adult patients on home parenteral nutrition (HPN) with a benign underlying disease using a two-round Delphi approach
  81. Quality of care for cancer patients on home parenteral nutrition: development of key interventions and outcome indicators using a two-round Delphi approach
  82. Assessment of Quality of Life on Home Parenteral Nutrition and After Intestinal Transplantation Using Treatment-Specific Questionnaires
  83. Outcome on home parenteral nutrition for benign intestinal failure: A review of the literature and benchmarking with the European prospective survey of ESPEN
  84. Home parenteral nutrition: An international benchmarking exercise
  85. The Authors' reply: Table 1
  86. Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation
  87. Fish oil-based emulsion for the treatment of parenteral nutrition associated liver disease in an adult patient
  88. Comprehensive Surgical Intestinal Rescue and Transplantation Program in Adult Patients: Bologna Experience
  89. Daclizumab and Alemtuzumab as Induction Agents in Adult Intestinal and Multivisceral Transplantation: Rejection and Infection Rates in 40 Recipients During the Early Postoperative Period
  90. Intestinal Transplantation
  91. ESPEN Guidelines on Parenteral Nutrition: Home Parenteral Nutrition (HPN) in adult patients
  92. Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab
  93. Parvovirus B19 Infection Localized in the Intestinal Mucosa and Associated with Severe Inflammatory Bowel Disease
  94. The complex relationship between magnesium and serum parathyroid hormone: a study in patients with chronic intestinal failure
  95. Survival of Patients Identified as Candidates for Intestinal Transplantation: A 3-Year Prospective Follow-Up
  96. Vitamin A and Vitamin E Isoforms Stability and Peroxidation Potential of All-In-One Admixtures for Parenteral Nutrition
  97. Collaborative Strategies to Reduce Mortality and Morbidity in Patients With Chronic Intestinal Failure Including Those Who Are Referred for Small Bowel Transplantation
  98. Cholestasis Induced by Total Parenteral Nutrition
  99. Management of intestinal failure in Europe. A questionnaire based study on the incidence and management
  100. Italian Experience in Adult Clinical Intestinal and Multivisceral Transplantation: 6 Years Later
  101. Rejection Episodes and 3-Year Graft Survival Under Sirolimus and Tacrolimus Treatment After Adult Intestinal Transplantation
  102. Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period
  103. Steroids in intestinal transplantation
  104. Twenty-five consecutive isolated intestinal transplants in adult patients: a five-yr clinical experience
  105. Prevalence of home artificial nutrition in Italy in 2005: A survey by the Italian Society for Parenteral and Enteral Nutrition (SINPE)
  106. Effect of Total Enterectomy, Pancreatectomy, and Portal Vein Ligation on Liver Function and Histology: A Case Report
  107. Recovery From Liver Dysfunction After Adult Isolated Intestinal Transplantation Without Liver Grafting
  108. Total parenteral nutrition-related gastroenterological complications
  109. Monitoring of patients on home parenteral nutrition (HPN) in Europe: A questionnaire based study on monitoring practice in 42 centres
  110. Candidates for Intestinal Transplantation: A Multicenter Survey in Europe
  111. Capsule endoscopy revealing small-intestinal lymphangiectasia and GI stromal tumor polyps in neurofibromatosis type 1
  112. Endogenous ethanol production in a patient with chronic intestinal pseudo-obstruction and small intestinal bacterial overgrowth
  113. Quality of Life on Home Parenteral Nutrition or After Intestinal Transplantation
  114. Results of Intestinal and Multivisceral Transplantation in Adult Patients: Italian Experience
  115. Role of citrulline in rejection monitoring after bowel transplantation
  116. Surgical Approach to Complicated Intestinal Failure for Benign Disease in Adult Patients: Transplantation or Surgical Rehabilitation?
  117. Octreotide in the outpatient therapy of cirrhotic chylous ascites: A case report
  118. Twenty-Seven Consecutive Intestinal and Multivisceral Transplants in Adult Patients: A 4-Year Clinical Experience
  119. Bone mineral density in patients on home parenteral nutrition: a follow-up study
  120. Intestinal Transplantation for Chronic Intestinal Pseudo-Obstruction in Adult Patients
  121. Erratum to “Effects of the September 2003, 28 blackout in Italy in patients on home parenteral nutrition (HPN)”
  122. Italian guidelines for intestinal transplantation: potential candidates among the adult patients managed by a medical referral center for chronic intestinal failure
  123. The SF-36 instrument for the follow-up of health-related quality-of-life assessment of patients undergoing home parenteral nutrition for benign disease
  124. Three-year experience in clinical intestinal transplantation
  125. Effects of the September 28 2003 blackout in Italy in patients on home parenteral nutrition (HPN)
  126. Peroxidation potential of lipid emulsions after compounding in all-in-one solutions
  127. Safety and efficacy of home parenteral nutrition for chronic intestinal failure: a 16-year experience at a single centre
  128. Central venous catheter complications in 447 patients on home parenteral nutrition: an analysis of over 100.000 catheter days
  129. Prevalence of bone disease in patients on home parenteral nutrition
  130. Quality of life and length of survival in advanced cancer patients on home parenteral nutrition
  131. Cost-benefit of home artificial nutrition regulation
  132. Clinical Nutrition is not a teenager any longer
  133. Nitrogen sparing effect of structured triglycerides containing both medium-and long-chain fatty acids in critically ill patients; a double blind randomized controlled trial
  134. Timely nutrition screen for hospital patients
  135. Bone turnover in short-term and long-term home parenteral nutrition for benign disease
  136. Nutrition parentérale à domicile chez l'adulte : enquête multicentrique en Europe en 1993 ESPEN — Home Artificial Nutrition Working Group
  137. Bone turnover in patients on home parenteral nutrition: alongitudinal observation by biochemical markers
  138. Chronic intestinal pseudo-obstruction
  139. Cost-benefit and cost-effectiveness analysis ofhome artificial nutrition: reappraisal of available data
  140. Possible role of structural lipids in artificial nutrition: comparison of a linoleic acid-based with an oleic acid-based enteral formula in humans
  141. Nutritional status of patients undergoing ileal pouch-anal anastomosis
  142. Relationship between intestinal permeability to [51Cr]EDTA and inflammatory activity in asymptomatic patients with Crohn's disease
  143. Urinary zinc excretion in Crohn's disease
  144. Circadian rhythm of gastric inhibitory polypeptide (GIP) in man
  145. Adrenergic modulation of gastric inhibitory polypeptide secretion in man
  146. Gastric Inhibitory Polypeptide Release after Oral Glucose: Relationship to Glucose Intolerance, Diabetes Mellitus, and Obesity
  147. Effect of Somatostatin on Fasting and Glucose-Stimulated Gastric Inhibitory Polypeptide Release in Man